Skip to content
buyWeak

Louis C. Lucido bought $4,170 of BICX

President at BioCorRx Inc.. 5,000 shares at an average of $0.83, traded Dec 12, 2022, filed Dec 15, 2022.

Conviction score
36
Value
$4,170
5,000 shares
Holdings after
89,425
+6% from before
From 52-week low
0%
low $0.80, close $0.80
From 52-week high
-84%
high $4.92, as of Dec 12, 2022

Score components

  • Role
    Director
    +15
  • Trade size
    $4k at market
    0
  • Relative to holdings
    Holdings up 6%
    +3
  • Price context
    0% above the 52-week low; 84% below the 52-week high
    +18
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Too few past buys to judge (1 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

BICXOct 12, 2026 · close 0.25
Since filing Dec 15, 2022: -68.8%SPY +110.3% · excess -179.1%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001477932-22-009312, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Dec 12, 2022POpen-market purchase
Common Stock, par value $0.001
+1,000$0.79$79085,425Dec 15, 2022
Dec 12, 2022POpen-market purchase
Common Stock, par value $0.001
+1,000$0.98$98086,425Dec 15, 2022
Dec 12, 2022POpen-market purchase
Common Stock, par value $0.001
+1,000$0.80$80087,425Dec 15, 2022
Dec 12, 2022POpen-market purchase
Common Stock, par value $0.001
+2,000$0.80$1,60089,425Dec 15, 2022

Related signals

Other insiders at BioCorRx Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
33Weak
BICXbuy
BioCorRx Inc.
Louis C. Lucido
Interim President
$2,188
3,126 shares
+1%
33Weak
BICXbuy
BioCorRx Inc.
Louis C. Lucido
President
$3,126
1,590 shares
+2%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Louis C. Lucido bought $4,170 of BICX | InsiderTell